Cellcept 250mg Capsule

CellCept 250mg Capsule contains mycophenolate mofetil 250mg, an immunosuppressive medicine used in combination with other medicines to help prevent organ rejection following kidney, heart, and liver transplantation. CellCept is the reference brand of mycophenolate mofetil marketed by Roche/Genentech. It works by suppressing the activity of certain immune cells involved in the body's rejection response.

CellCept 250mg is a prescription immunosuppressant and should be used only under the supervision of a transplant specialist or qualified healthcare professional. It is important to follow the prescribed regimen and monitoring schedule because immunosuppressive treatment can increase susceptibility to infections and requires ongoing medical monitoring.

Product Information

Generic Name

Mycophenolate Mofetil 250mg

Brand Name

CellCept®

Drug Class

Immunosuppressant

Therapeutic Class

Antimetabolite / Immunosuppressive Agent

Active Ingredient

Mycophenolate Mofetil

Strength

250mg

Dosage Form

Capsule

Route

Oral

Indication

Prevention of organ rejection following kidney, heart, and liver transplantation

Prescription

Yes

Packing

Manufacturer Dependent

Manufacturer

Product/Brand Dependent

What Is CellCept 250mg Capsule?

CellCept 250mg Capsule is an oral formulation containing mycophenolate mofetil, an immunosuppressive medicine.

It is used together with other immunosuppressants and corticosteroids in transplant recipients to reduce the risk of the immune system attacking the transplanted organ.

Mycophenolate mofetil is converted in the body to mycophenolic acid (MPA), its active form. MPA inhibits inosine monophosphate dehydrogenase, an enzyme required for the proliferation of certain lymphocytes. This reduces the ability of immune cells to mount an immune response against the transplanted organ.

CellCept 250mg vs Mycophenolate Mofetil

CellCept® is a branded product containing mycophenolate mofetil.

Mycophenolate mofetil 250mg manufactured by another pharmaceutical company may contain the same active ingredient and strength, but the manufacturer, formulation, inactive ingredients, packaging and regulatory authorization can differ.

Patients should not switch between formulations without guidance from their healthcare professional, particularly after transplantation.

Generic CellCept 250mg

Generic CellCept 250mg generally refers to an authorized mycophenolate mofetil 250mg product intended as an alternative to the CellCept brand.

Commercially relevant search relationships include:

CellCept 250mg → Mycophenolate Mofetil 250mg → Generic CellCept 250mg → Mycophenolate Mofetil 250mg Capsule → CellCept Alternative

Only describe a product as a generic equivalent where that status is supported by the applicable regulatory authorization.

Availability & Ordering

CellCept 250mg Capsule and authorized mycophenolate mofetil alternatives are prescription medicines. Availability and dispensing requirements vary by country.

Customers searching for CellCept 250mg Capsule, Mycophenolate Mofetil 250mg, Generic CellCept 250mg, Mycophenolate Mofetil 250mg Capsule, Buy CellCept 250mg, CellCept 250mg Price, Generic Mycophenolate Mofetil and related terms can check availability through appropriately licensed pharmacies and pharmaceutical suppliers.

Prescription and importation requirements differ across the USA, UK, UAE/Dubai, Australia, Singapore, Thailand, China and Russia.

How it works

CellCept contains mycophenolate mofetil, which is converted to mycophenolic acid in the body.

Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme involved in purine synthesis. Because certain lymphocytes depend heavily on this pathway for proliferation, inhibition reduces the proliferation of T and B lymphocytes and suppresses immune activity.

This immunosuppressive effect helps reduce the likelihood that the body will reject a transplanted organ.

CellCept 250mg may be prescribed as part of an immunosuppressive regimen to help prevent rejection after:

• Kidney transplantation
• Heart transplantation
• Liver transplantation

It is generally used in combination with other transplant medicines rather than as a standalone treatment.

The dose of CellCept is determined by the transplant team according to the type of transplant, other immunosuppressive medicines being used, kidney or liver function, tolerability and individual clinical factors.

CellCept should be taken exactly as prescribed. Do not change the dose, stop treatment or substitute another mycophenolate product without consulting the transplant specialist.

The 250mg capsule is a dosage form of mycophenolate mofetil and may be used as part of an individualized dosing regimen.